血管内超声指导与造影指导经皮冠状动脉介入治疗在急性冠脉综合征中的比较(IVUS-ACS):一项两阶段、多中心、随机试验
IVUS-ACS为两阶段、多中心、随机试验,纳入中国、意大利、巴基斯坦和英国58个中心3505例急性冠脉综合征患者,随机分入血管内超声指导经皮冠状动脉介入治疗组(n=1753)或造影指导组(n=1752)。主要终点为随机化后1年靶血管失败(心源性死亡、靶血管心肌梗死或临床驱动的靶血管血运重建的复合终点)。血管内超声组主要终点发生70例,造影组128例(Kaplan-Meier率4.0% vs 7.3%;HR 0.55,95%CI 0.41-0.74;p=0.0001),差异由靶血管心肌梗死或靶血管血运重建减少驱动。两组全因死亡或支架血栓无显著差异,安全性终点相似。
要点
- 急性冠脉综合征患者随机接受血管内超声指导或造影指导PCI,1年靶血管失败率血管内超声组4.0% vs 造影组7.3%(HR 0.55,95%CI 0.41-0.74;p=0.0001)。
- 主要终点差异由靶血管心肌梗死或靶血管血运重建减少驱动。
- 两组全因死亡或支架血栓无显著差异,安全性终点相似。
- 1年随访在3504例(>99.9%)患者中完成。
- 研究在58个中心纳入3505例急性冠脉综合征患者,随机分组为血管内超声组1753例、造影组1752例。
适用人群与场景
- 年龄18岁及以上、表现为急性冠脉综合征的患者,来自中国、意大利、巴基斯坦和英国的58个中心。
研究设计与关键结果
- 研究类型:两阶段、多中心、随机试验;样本量3505例(血管内超声组1753例,造影组1752例);58个中心;人群为急性冠脉综合征患者;干预为血管内超声指导经皮冠状动脉介入治疗,对照为造影指导经皮冠状动脉介入治疗。
- 主要终点(随机化后1年靶血管失败:心源性死亡、靶血管心肌梗死或临床驱动的靶血管血运重建的复合终点):血管内超声组70例 vs 造影组128例(Kaplan-Meier率4.0% vs 7.3%;HR 0.55,95%CI 0.41-0.74;p=0.0001),差异由靶血管心肌梗死或靶血管血运重建减少驱动。
- 全因死亡或支架血栓两组间无显著差异;安全性终点两组相似。
- 1年随访在3504例(>99.9%)患者中完成。
- 随机化时间范围:2019年8月20日至2022年10月27日。
证据类型、等级与局限
- 证据类型:随机对照试验(两阶段、多中心、随机试验)。
- 患者、随访医疗提供者和评估者对随机分组设盲;导管室工作人员未设盲。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在急性冠脉综合征患者中,血管内超声指导当代药物洗脱支架置入较单纯造影指导降低1年心源性死亡、靶血管心肌梗死或临床驱动血运重建复合结局发生率。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Intravascular ultrasound-guided percutaneous coronary intervention has been shown to result in superior clinical outcomes compared with angiography-guided percutaneous coronary intervention. However, insufficient data are available concerning the advantages of intravascular ultrasound guidance for patients with an acute coronary syndrome. This trial aimed to investigate whether the use of intravascular ultrasound guidance, as compared with angiography guidance, improves the outcomes of percutaneous coronary intervention with contemporary drug-eluting stents in patients presenting with an acute coronary syndrome.
METHODS: In this two-stage, multicentre, randomised trial, patients aged 18 years or older and presenting with an acute coronary syndrome at 58 centres in China, Italy, Pakistan, and the UK were randomly assigned to intravascular ultrasound-guided percutaneous coronary intervention or angiography-guided percutaneous coronary intervention. Patients, follow-up health-care providers, and assessors were masked to random assignment; however, staff in the catheterisation laboratory were not. The primary endpoint was target vessel failure, a composite of cardiac death, target vessel myocardial infarction, or clinically driven target vessel revascularisation at 1 year after randomisation. This trial is registered at ClinicalTrials.gov, NCT03971500, and is completed.
FINDINGS: Between Aug 20, 2019 and Oct 27, 2022, 3505 patients with an acute coronary syndrome were randomly assigned to intravascular ultrasound-guided percutaneous coronary intervention (n=1753) or angiography-guided percutaneous coronary intervention (n=1752). 1-year follow-up was completed in 3504 (>99·9%) patients. The primary endpoint occurred in 70 patients in the intravascular ultrasound group and 128 patients in the angiography group (Kaplan-Meier rate 4·0% vs 7·3%; hazard ratio 0·55 [95% CI 0·41-0·74]; p=0·0001), driven by reductions in target vessel myocardial infarction or target vessel revascularisation. There were no significant differences in all-cause death or stent thrombosis between groups. Safety endpoints were also similar in the two groups.
INTERPRETATION: In patients with an acute coronary syndrome, intravascular ultrasound-guided implantation of contemporary drug-eluting stents resulted in a lower 1-year rate of the composite outcome of cardiac death, target vessel myocardial infarction, or clinically driven revascularisation compared with angiography guidance alone.
FUNDING: The Chinese Society of Cardiology, the National Natural Scientific Foundation of China, and Jiangsu Provincial & Nanjing Municipal Clinical Trial Project.
TRANSLATION: For the Mandarin translation of the abstract see Supplementary Materials section.
参考来源
- Li X, Ge Z, Kan J, et al. Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes (IVUS-ACS): a two-stage, multicentre, randomised trial. Lancet. 2024. PMID: 38604212. doi:10.1016/S0140-6736(24)00282-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。